Standard Treatment for Herpes During Pregnancy
Famciclovir, an antiviral used for herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections, is category B under the old FDA system (animal studies show no risk, limited human data). It's often avoided in pregnancy due to lack of extensive safety data, with acyclovir preferred as first-line by CDC and ACOG guidelines for genital herpes suppression in late pregnancy to reduce neonatal transmission risk.[1][2]
Acyclovir as Primary Alternative
Acyclovir (Zovirax) is the go-to substitute, classified as category B with decades of human data showing no increased birth defects. It's given IV for severe cases like disseminated HSV or orally for suppression from 36 weeks gestation. Studies of over 2,000 exposed pregnancies report malformation rates similar to the general population (around 3%).[1][3]
Valacyclovir as Another Option
Valacyclovir (Valtrex), an acyclovir prodrug with better oral bioavailability, is also category B and widely used. It achieves higher acyclovir levels with less frequent dosing. Registry data from thousands of exposures confirm safety, with no signals for adverse outcomes like preterm birth or congenital anomalies beyond baseline risks.[2][4]
How These Compare to Famciclovir
All three are nucleoside analogs targeting viral DNA polymerase, but famciclovir converts to penciclovir, which has less pregnancy data. Acyclovir and valacyclovir have stronger evidence from prospective studies; famciclovir relies more on animal models and post-marketing reports. No head-to-head trials exist in pregnancy, but guidelines prioritize acyclovir/valacyclovir for efficacy equivalence and safety profile.[1][2]
What About Topical or Other Alternatives
Topical acyclovir is safe for lesions but insufficient for systemic suppression. For VZV (chickenpox/shingles), IV acyclovir is standard; oral alternatives are limited. Non-antiviral options like supportive care (pain relief, hydration) don't address viral replication. Vaccines (e.g., shingles vaccine) are contraindicated in pregnancy.[3][5]
Risks and When to Use Antivirals
Untreated HSV in pregnancy risks neonatal herpes (30-50% mortality if disseminated). Suppression cuts cesarean rates and transmission. Consult OB/GYN or ID specialist; dosing adjusts for renal function. No alternatives match efficacy for severe cases.[2][6]
Sources
[1] CDC Herpes Guidelines
[2] ACOG Genital Herpes in Pregnancy
[3] MotherToBaby Acyclovir Fact Sheet
[4] Valacyclovir Pregnancy Registry
[5] UpToDate Antivirals in Pregnancy
[6] NEJM Neonatal Herpes Review